Madam Speaker, at the beginning of the pandemic we announced some significant investments in the most promising Canadian candidates. Dr. Kobinger said that Medicago was the first vaccine candidate he would look at. We agree, which is why we invested up to $173 million to help Medicago move forward with its vaccine candidate and to restore a large-scale biomanufacturing facility in Quebec City. We invested $1 million in Dr. Kobinger's research, through an independent, peer-reviewed process. We are very pleased that the Government of Quebec has announced it also plans to support this research.
In the House of Commons on February 26th, 2021. See this statement in context.